Kellerhals Carrard advised Swiss deep tech company Jua.ai AG on its USD 11M Series A financing Round. The context Headquartered in Zurich, Jua.ai AG specialises on AI-based Earth simulation aimed at transforming
Tags :Kellerhals Carrard
Kellerhals Carrard advised DRS Investment on the acquisition of a controlling interest in the newly formed factory group. The context A merger of Germany’s VIGNOLD Group and Swiss marketing service provider The Factory, the
Kellerhals Carrard advised Maestrani Schweizer Schokoladen on taking over the production infrastructure for chocolate-coated marshmallow treats (Schokoladenküsse) from Chocolat Ammann. The context Pursuant to the acquisition, the Swiss family-owned company further expands its brand
Kellerhals Carrard advises SKAN on its acquisition of Metronik. The SIX-listed Swiss company, specialised in isolator systems for the (bio-) pharmaceutical industry, has signed an agreement acquire a 76% stake in the Slovenian Metronik, a
Kellerhals Carrard advised Groupe Minoteries on its takeover of the traditional Schweizerische Schälmühle E. Zwicky. The context Pursuant to the transaction, the long-term succession of the Klopfenstein family will be preserved and the
Swiss precision medicines company Haya Therapeutics completed a $65 million series A funding round. In connection with the deal, Kellerhals Carrard represented lead investors Sofinnova Partners and Earlybird Venture Capital, while Lenz & Staehelin assisted Eli
Kellerhals Carrard advised Vaud-based start-up NovaMea and its founder Xile Hu in connection with a 9M USD series A financing round. The context Several international VCs led the capital round in question, with all proceeds
Kellerhals Carrard advised Basel-based CGC Genomics Consults on all legal aspects of their pre-seed financing round. Pursuant to the transaction, the Swiss startup secured approximately EUR 1.7 million. The context Several impact and health-tech investors led
Banking & Finance Baker McKenzie advised UBS Switzerland and a syndicate of Swiss banks on the conclusion of a syndicated credit facility agreement for Mercedes-Benz Automobil (Merbag). The proceeds of the facility in question will
Kellerhals Carrard advised Burgdorf-based TecMed as lead counsel on the company’s acquisition of Ypsomed’s diabetes care business for CHF 420 million, including earn-out. Moreover, Walder Wyss represented the selling part throughout the transaction. Closing
